NEWS

2026年01月08日

iCONM in collaboration with BioLabs has been mentioned in an in-depth analysis article published by BioSpectrum Asia titled “Japan Pushes Startups to Power the Next Biotech Cycle.” The article (released on January 3, 2026) highlights Japan’s recent policy-driven efforts to strengthen its biopharmaceutical startup ecosystem. It covers key initiatives such as expanded venture funding, targeted subsidies for drug development, and tax incentives aimed at investors, entrepreneurs, and startup employees. iCONM with BioLabs is referenced as part of Japan’s growing push to accelerate innovation and translate cutting-edge research into real-world biotech solutions.